Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
36.91
-1.15 (-3.02%)
Jul 31, 2026, 10:25 AM EDT - Market open
Rigel Pharmaceuticals Market Cap
Rigel Pharmaceuticals has a market cap or net worth of $682.91 million as of July 31, 2026. Its market cap has increased by 81.87% in one year.
Market Cap
682.91M
Enterprise Value
589.35M
1-Year Change
81.87%
Ranking
Category
Stock Price
$36.91
ChartMarket Cap Chart
Since November 29, 2000, Rigel Pharmaceuticals's market cap has increased from $254.90M to $682.91M, an increase of 167.91%. That is a compound annual growth rate of 3.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 682.91M | -12.15% |
| Dec 31, 2025 | 777.40M | 162.37% |
| Dec 31, 2024 | 296.30M | 17.21% |
| Dec 29, 2023 | 252.80M | -2.51% |
| Dec 30, 2022 | 259.30M | -42.78% |
| Dec 31, 2021 | 453.20M | -23.37% |
| Dec 31, 2020 | 591.40M | 64.87% |
| Dec 31, 2019 | 358.70M | -6.42% |
| Dec 31, 2018 | 383.30M | -32.57% |
| Dec 29, 2017 | 568.40M | 141.36% |
| Dec 30, 2016 | 235.50M | -12.19% |
| Dec 31, 2015 | 268.20M | 34.57% |
| Dec 31, 2014 | 199.30M | -20.02% |
| Dec 31, 2013 | 249.20M | -55.93% |
| Dec 31, 2012 | 565.50M | 0.60% |
| Dec 30, 2011 | 562.10M | 43.14% |
| Dec 31, 2010 | 392.70M | -20.31% |
| Dec 31, 2009 | 492.80M | 68.36% |
| Dec 31, 2008 | 292.70M | -62.86% |
| Dec 31, 2007 | 788.20M | 164.67% |
| Dec 29, 2006 | 297.80M | 47.43% |
| Dec 30, 2005 | 202.00M | -57.71% |
| Dec 31, 2004 | 477.70M | 68.26% |
| Dec 31, 2003 | 283.90M | 465.54% |
| Dec 31, 2002 | 50.20M | -71.28% |
View and export this data all the way back to 2000. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bright Minds Biosciences | 731.41M |
| Candel Therapeutics | 728.31M |
| Phathom Pharmaceuticals | 719.64M |
| Pharming Group | 712.11M |
| Nuvectis Pharma | 711.53M |
| CytomX Therapeutics | 699.91M |
| Climb Bio | 690.56M |
| BridgeBio Oncology Therapeutics | 680.91M |